Tango Therapeutics, Inc.

Go to Tango Therapeutics, Inc. Website

$6.91

0.00 (0.00%)
Live
Previous Close

$6.91

Day Range

$0 - $0

Previous Day Range

$6.3406 - $7.07

Market Cap

$714.3 million USD

Day Vol.

0

Previous Day Vol.

2.3 million

Currency

USD

Primary Exchange

Nasdaq

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing pre...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Tango Therapeutics reported a steep decline in Q2 2025 revenue and wider net losses, with ongoing clinical trials in targeted oncology therapies and the early termination of its Gilead partnership.

Related tickers: TNGX, GILD, RVMD, RVMDW.

Read Full Article

Tango Therapeutics initiated a Phase 1/2 clinical trial combining TNG462 with Revolution Medicines' daraxonrasib or zoldonrasib to treat RAS-mutant MTAP-deleted pancreatic and lung cancers, targeting potential new precision cancer therapies.

Related tickers: TNGX, RVMD, RVMDW.

Read Full Article
Trending Tickers

Please sign in to view